InAADR

Drug Information

Drug Name: Neurotensin (39379-15-2)
PubChem ID: 25078013
SMILES: CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC(C)C)NC(=O)C5CCC(=O)N5
InchiKey: PCJGZPGTCUMMOT-UHFFFAOYSA-N
Therapeutic Category:

Computed Drug Properties

Molecular Weight (dalton): 1672.95
LogP: -3.8091
Ring Count: 2
Hydrogen Bond Acceptor Count: 21
Hydrogen Bond Donor Count: 21
Total Polar Surface Area: 673.69

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference
Hypotensive Renin (P00797) NT produces part of its hypotensive effect in anesthetized rats by reducing the activity of the renin angiotensin system. [ ADR Type 1 ] Partial blockade of neurotensin-induced hypotension in rats by nephrectomy captopril and saralasin Possible mechanisms

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source

InAADR: Drug-Protein-ADRs database